2BBBullish & Bearish
Tonix Pharmaceuticals Holding Corp. (TNXP) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 36 out of 100.
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
Tonix Pharmaceuticals Holding Corp.’s current 2BB score is 36 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 78 | Strong |
| Quality | 100 | Very Strong |
| Risk | 9 | Very Low |
| CEO | Seth Lederman |
| Headquarters | Berkeley Heights, New Jersey, United States |
| Founded | 2007 |
| Employees | 142 |
| 52-week range | $10.06 – $69.96 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | -2.5636 | — | $9.42M |
| 2026-08-10 | — | -2.7506 | — | $7.88M |
| 2026-05-11 | — | -2.6265 | — | $13.21M |
| 2026-03-16 | — | -3.2538 | — | $3.03M |